{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:02:38Z","timestamp":1789650158671,"version":"4.0.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,17]]},"DOI":"10.7759\/cureus.116417","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:12:04Z","timestamp":1789647124000},"source":"Crossref","is-referenced-by-count":0,"title":["Renal-Limited Thrombotic Microangiopathy Presenting as Acute on Chronic Kidney Failure in the Absence of Schistocytosis"],"prefix":"10.7759","author":[{"given":"Raylee E","family":"Warren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Elizondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufiyan","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George JN","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014, 371:654-66. 10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.10.014","article-title":"Renal thrombotic microangiopathy: A review","volume":"81","author":"Genest DS","year":"2023","unstructured":"Genest DS, Patriquin CJ, Licht C, John R, Reich HN. Renal thrombotic microangiopathy: A review. Am J Kidney Dis. 2023, 81:591-605. 10.1053\/j.ajkd.2022.10.014","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.akdh.2023.09.003","article-title":"Thrombotic microangiopathies and the kidney","volume":"31","author":"Java A","year":"2024","unstructured":"Java A, Burwick R, Chang A. Thrombotic microangiopathies and the kidney. Adv Kidney Dis Health. 2024, 31:255-64. 10.1053\/j.akdh.2023.09.003","journal-title":"Adv Kidney Dis Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.10.006","article-title":"AJKD Atlas of Renal Pathology: thrombotic microangiopathy","volume":"68","author":"Lusco MA","year":"2016","unstructured":"Lusco MA, Fogo AB, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: thrombotic microangiopathy. Am J Kidney Dis. 2016, 68:e33-4. 10.1053\/j.ajkd.2016.10.006","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.02.014","article-title":"Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies","volume":"105","author":"Maisons V","year":"2024","unstructured":"Maisons V, Duval A, Mesnard L, et al.. Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies. Kidney Int. 2024, 105:1100-12. 10.1016\/j.kint.2024.02.014","journal-title":"Kidney Int"},{"key":"ref6","unstructured":"American Board of  Internal Medicine. Laboratory reference ranges (revised January 2026). (2026). Accessed. September 12, 2026: https:\/\/www.abim.org\/media\/e2wdwdqu\/laboratory-reference-ranges.pdf."},{"key":"ref7","unstructured":"National Kidney Foundation. Estimated glomerular filtration rate (eGFR). Kidney function levels, stages, and what to do next. (2026). Accessed: September 12, 2026: https:\/\/www.kidney.org\/kidney-topics\/estimated-glomerular-filtration-rate-egfr."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100690","article-title":"Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy","volume":"38","author":"van Doorn DP","year":"2025","unstructured":"van Doorn DP, Tobal R, Abdul-Hamid MA, van Paassen P, Timmermans SA. Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy. Mod Pathol. 2025, 38:100690. 10.1016\/j.modpat.2024.100690","journal-title":"Mod Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank V","year":"2018","unstructured":"Brocklebank V, Wood KM, Kavanagh D. Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol. 2018, 13:300-17. 10.2215\/CJN.00620117","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01181","article-title":"Antiphospholipid syndrome nephropathy: From pathogenesis to treatment","volume":"9","author":"Tektonidou MG","year":"2018","unstructured":"Tektonidou MG. Antiphospholipid syndrome nephropathy: From pathogenesis to treatment. Front Immunol. 2018, 9:1181. 10.3389\/fimmu.2018.01181","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.12.009","article-title":"Patients with hypertension-associated thrombotic\u00a0microangiopathy may present with\u00a0complement abnormalities","volume":"91","author":"Timmermans SA","year":"2017","unstructured":"Timmermans SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, Reutelingsperger CP, van Paassen P. Patients with hypertension-associated thrombotic\u00a0microangiopathy may present with\u00a0complement abnormalities. Kidney Int. 2017, 91:1420-5. 10.1016\/j.kint.2016.12.009","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma LM","year":"2021","unstructured":"Palma LM, Sridharan M, Sethi S. Complement in secondary thrombotic microangiopathy. Kidney Int Rep. 2021, 6:11-23. 10.1016\/j.ekir.2020.10.009","journal-title":"Kidney Int Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13954","article-title":"Diagnosis and treatment of thrombotic microangiopathy","volume":"44 Suppl 1","author":"Thompson GL","year":"2022","unstructured":"Thompson GL, Kavanagh D. Diagnosis and treatment of thrombotic microangiopathy. Int J Lab Hematol. 2022, 44 Suppl 1:101-13. 10.1111\/ijlh.13954","journal-title":"Int J Lab Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2026.2617722","article-title":"Long-term renal outcomes of patients with biopsy-proven malignant hypertension-associated renal thrombotic microangiopathy who are dialysis-independent at baseline","volume":"48","author":"Li J","year":"2026","unstructured":"Li J, Li Y, Zhong Z, et al.. Long-term renal outcomes of patients with biopsy-proven malignant hypertension-associated renal thrombotic microangiopathy who are dialysis-independent at baseline. Ren Fail. 2026, 48:2617722. 10.1080\/0886022X.2026.2617722","journal-title":"Ren Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2022.2161396","article-title":"Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy","volume":"45","author":"Chen FF","year":"2023","unstructured":"Chen FF, Yu XJ, Wang H, et al.. Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy. Ren Fail. 2023, 45:2161396. 10.1080\/0886022X.2022.2161396","journal-title":"Ren Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/521343-renal-limited-thrombotic-microangiopathy-presenting-as-acute-on-chronic-kidney-failure-in-the-absence-of-schistocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:12:08Z","timestamp":1789647128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/521343-renal-limited-thrombotic-microangiopathy-presenting-as-acute-on-chronic-kidney-failure-in-the-absence-of-schistocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.116417","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}